Compare QUIK & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QUIK | TKNO |
|---|---|---|
| Founded | 1988 | 1996 |
| Country | United States | United States |
| Employees | 51 | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.6M | 268.1M |
| IPO Year | 1997 | 2021 |
| Metric | QUIK | TKNO |
|---|---|---|
| Price | $12.67 | $7.24 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 292.3K | 167.5K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | $20,112,000.00 | ★ $40,520,000.00 |
| Revenue This Year | $75.17 | $8.27 |
| Revenue Next Year | $16.04 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $4.80 | $1.91 |
| 52 Week High | $24.33 | $7.84 |
| Indicator | QUIK | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 74.88 |
| Support Level | $11.76 | $3.79 |
| Resistance Level | $14.81 | N/A |
| Average True Range (ATR) | 0.95 | 0.55 |
| MACD | 0.13 | 0.20 |
| Stochastic Oscillator | 35.98 | 80.06 |
QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.